Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

331 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
PML with dimethyl fumarate-No role for natalizumab?
Berger JR. Berger JR. Mult Scler. 2019 Oct;25(12):1686-1687. doi: 10.1177/1352458519872897. Epub 2019 Aug 22. Mult Scler. 2019. PMID: 31436127 No abstract available.
The effect of dimethyl fumarate (Tecfideraâ„¢) on lymphocyte counts: A potential contributor to progressive multifocal leukoencephalopathy risk.
Khatri BO, Garland J, Berger J, Kramer J, Sershon L, Olapo T, Sesing J, Dukic M, Rehn E. Khatri BO, et al. Mult Scler Relat Disord. 2015 Jul;4(4):377-9. doi: 10.1016/j.msard.2015.05.003. Epub 2015 May 14. Mult Scler Relat Disord. 2015. PMID: 26195059
Editorial for JNV issue on PML.
Berger JR. Berger JR. J Neurovirol. 2015 Dec;21(6):599-600. doi: 10.1007/s13365-015-0376-5. Epub 2015 Sep 2. J Neurovirol. 2015. PMID: 26329137 No abstract available.
Reassessing the risk of natalizumab-associated PML.
Berger JR, Fox RJ. Berger JR, et al. J Neurovirol. 2016 Aug;22(4):533-5. doi: 10.1007/s13365-016-0427-6. Epub 2016 Feb 3. J Neurovirol. 2016. PMID: 26843383
Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy.
Hoepner R, Kolb EM, Dahlhaus S, Hellwig K, Adams O, Kleiter I, Salmen A, Schneider R, Lukas C, Chan A, Berger JR, Gold R. Hoepner R, et al. Mult Scler. 2017 May;23(6):830-835. doi: 10.1177/1352458516667241. Epub 2016 Sep 6. Mult Scler. 2017. PMID: 27600113
Classifying PML risk with disease modifying therapies.
Berger JR. Berger JR. Mult Scler Relat Disord. 2017 Feb;12:59-63. doi: 10.1016/j.msard.2017.01.006. Epub 2017 Jan 6. Mult Scler Relat Disord. 2017. PMID: 28283109 Review.
Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR).
Sabol RA, Noxon V, Sartor O, Berger JR, Qureshi Z, Raisch DW, Norris LB, Yarnold PR, Georgantopoulos P, Hrushesky WJ, Bobolts L, Ray P, Lebby A, Kane RC, Bennett CL. Sabol RA, et al. Cancer Med. 2017 Jul;6(7):1541-1551. doi: 10.1002/cam4.1098. Epub 2017 Jun 20. Cancer Med. 2017. PMID: 28635055 Free PMC article. Review.
The financial contribution of the multiple sclerosis specialist.
Berger JR. Berger JR. Neurol Clin Pract. 2017 Jun;7(3):246-255. doi: 10.1212/CPJ.0000000000000360. Neurol Clin Pract. 2017. PMID: 30107024 Free PMC article. Review.
331 results
Jump to page
Feedback